Wei‐Han Hu

2.8k total citations
44 papers, 762 citations indexed

About

Wei‐Han Hu is a scholar working on Otorhinolaryngology, Oncology and Surgery. According to data from OpenAlex, Wei‐Han Hu has authored 44 papers receiving a total of 762 indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Otorhinolaryngology, 21 papers in Oncology and 17 papers in Surgery. Recurrent topics in Wei‐Han Hu's work include Head and Neck Cancer Studies (25 papers), Lung Cancer Research Studies (9 papers) and Head and Neck Surgical Oncology (8 papers). Wei‐Han Hu is often cited by papers focused on Head and Neck Cancer Studies (25 papers), Lung Cancer Research Studies (9 papers) and Head and Neck Surgical Oncology (8 papers). Wei‐Han Hu collaborates with scholars based in China, United States and Canada. Wei‐Han Hu's co-authors include Yamei Tang, Peijing Li, Rui Sun, Yongteng Xu, Xiaoming Rong, Ting Jin, Hui Lin, Wenqi Jiang, Yuchen Cai and Ying Jin and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and The Lancet Oncology.

In The Last Decade

Wei‐Han Hu

44 papers receiving 752 citations

Peers

Wei‐Han Hu
Zhongguo Liang China
Kie‐Kian Ang United States
Jay P. Reddy United States
Andreas Schröck Germany
Xiayun He China
Takatsugu Mizumachi Japan
Song Qu China
Ronny Kalash United States
Rou Jiang China
Tu Dan United States
Zhongguo Liang China
Wei‐Han Hu
Citations per year, relative to Wei‐Han Hu Wei‐Han Hu (= 1×) peers Zhongguo Liang

Countries citing papers authored by Wei‐Han Hu

Since Specialization
Citations

This map shows the geographic impact of Wei‐Han Hu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wei‐Han Hu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wei‐Han Hu more than expected).

Fields of papers citing papers by Wei‐Han Hu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wei‐Han Hu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wei‐Han Hu. The network helps show where Wei‐Han Hu may publish in the future.

Co-authorship network of co-authors of Wei‐Han Hu

This figure shows the co-authorship network connecting the top 25 collaborators of Wei‐Han Hu. A scholar is included among the top collaborators of Wei‐Han Hu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wei‐Han Hu. Wei‐Han Hu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ma, Jun, Ying Sun, Ye‐Lin Liang, et al.. (2024). Adjuvant PD-1 blockade with camrelizumab in high-risk locoregionally advanced nasopharyngeal carcinoma (DIPPER): A multicenter, open-label, phase 3, randomized controlled trial.. Journal of Clinical Oncology. 42(17_suppl). LBA6000–LBA6000. 13 indexed citations
2.
Tang, Ling‐Long, Chenglong Huang, Ning Zhang, et al.. (2022). Elective upper-neck versus whole-neck irradiation of the uninvolved neck in patients with nasopharyngeal carcinoma: an open-label, non-inferiority, multicentre, randomised phase 3 trial. The Lancet Oncology. 23(4). 479–490. 47 indexed citations
3.
Xu, Yongteng, Xiaoming Rong, Wei‐Han Hu, et al.. (2018). Bevacizumab Monotherapy Reduces Radiation-induced Brain Necrosis in Nasopharyngeal Carcinoma Patients: A Randomized Controlled Trial. International Journal of Radiation Oncology*Biology*Physics. 101(5). 1087–1095. 70 indexed citations
4.
Li, Peijing, Hao‐Yuan Mo, Dong–Hua Luo, Wei‐Han Hu, & Ting Jin. (2018). The efficacy of induction chemotherapy in the treatment of stage II nasopharyngeal carcinoma in intensity modulated radiotherapy era. Oral Oncology. 85. 95–100. 15 indexed citations
5.
He, Shasha, Yong Chen, Xiaoming Shen, et al.. (2017). DNA-dependent protein kinase catalytic subunit functions in metastasis and influences survival in advanced-stage laryngeal squamous cell carcinoma. Journal of Cancer. 8(12). 2410–2416. 4 indexed citations
6.
He, Shasha, Yong Chen, Hongzhi Wang, et al.. (2017). Loss of LKB1 Expression Decreases the Survival and Promotes Laryngeal Cancer Metastasis. Journal of Cancer. 8(17). 3548–3554. 3 indexed citations
7.
Jin, Ting, Peijing Li, Xiaozhong Chen, & Wei‐Han Hu. (2016). ABO blood group is a predictor of survival in patients with laryngeal cancer. Chinese Journal of Cancer. 35(1). 90–90. 11 indexed citations
8.
Li, Peijing, Ting Jin, Dong–Hua Luo, et al.. (2015). Effect of Prolonged Radiotherapy Treatment Time on Survival Outcomes after Intensity-Modulated Radiation Therapy in Nasopharyngeal Carcinoma. PLoS ONE. 10(10). e0141332–e0141332. 35 indexed citations
9.
Li, Peijing, Wei‐Han Hu, Yuan Zhu, & Jianjiang Liu. (2015). Treatment and predictive factors in patients with recurrent laryngeal carcinoma: A retrospective study. Oncology Letters. 10(5). 3145–3152. 22 indexed citations
10.
11.
Zhang, Zichen, et al.. (2014). HPV Infection and Anemia Status Stratify the Survival of Early T2 Laryngeal Squamous Cell Carcinoma. Journal of Voice. 29(3). 356–362. 16 indexed citations
12.
Xu, Tao, Bojin Su, Sumei Wang, et al.. (2014). Prognostic significance of circulating CD19+ B lymphocytes in EBV-associated nasopharyngeal carcinoma. Medical Oncology. 31(10). 198–198. 14 indexed citations
13.
14.
Cai, Xiuyu, Wei‐Han Hu, Bei Zhang, et al.. (2013). Genotyping of IL-8-251 T > A yields prognostic information in patients with gastric carcinoma. Biomarkers. 18(7). 559–564. 3 indexed citations
15.
Sun, Rui, et al.. (2013). P16INK4A as a surrogate biomarker for human papillomavirus‐associated oropharyngeal carcinoma: Consideration of some aspects. Cancer Science. 104(12). 1553–1559. 37 indexed citations
16.
Jin, Ting, Huan‐Xin Lin, Hui Lin, et al.. (2012). Expression TGM2 and BNIP3 have prognostic significance in laryngeal cancer patients receiving surgery and postoperative radiotherapy: A retrospective study. Journal of Translational Medicine. 10(1). 64–64. 23 indexed citations
17.
Zhang, Guoyi, Yizhuo Li, Tao Xu, et al.. (2011). The role of PET-CT in diagnosing distant metastasis of nasopharyngeal carcinoma. 23(5). 294–298. 2 indexed citations
18.
19.
Jin, Ting, Wei‐Han Hu, Libing Guo, et al.. (2011). Treatment results and prognostic factors of patients undergoing postoperative radiotherapy for laryngeal squamous cell carcinoma. Chinese Journal of Cancer. 30(7). 482–489. 6 indexed citations
20.
Xie, Fang‐Yun, et al.. (2010). Prophylactic irradiation of cervical lymph nodes for Stage-N0 nasopharyngeal carcinoma. Chinese Journal of Cancer. 29(1). 100–104. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Zhongguo Liang Breakdown of academic impact, for papers by Kie‐Kian Ang Breakdown of academic impact, for papers by Jay P. Reddy Breakdown of academic impact, for papers by Andreas Schröck Breakdown of academic impact, for papers by Xiayun He Breakdown of academic impact, for papers by Takatsugu Mizumachi Breakdown of academic impact, for papers by Song Qu Breakdown of academic impact, for papers by Ronny Kalash Breakdown of academic impact, for papers by Rou Jiang Breakdown of academic impact, for papers by Tu Dan
Rankless by CCL
2026